31 March 2025
EMA: First report on sale and use of antimicrobials in animals in the EU
The European Medicines Agency (EMA) has published its first European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet) annual surveillance report. For the first time, data collection and reporting of antimicrobial sales and use in animals were conducted under Article 57 of Regulation (EU) 2019/6 on veterinary medicinal products. In 2024, 29 reporting countries (27 EU countries, Iceland and Norway) reported 2023 data to the EMA on the volume of sales of antimicrobial veterinary medicinal products (VMPs) and on the use of antimicrobial medicinal products in animals under this legal framework.
The annual ESUAvet reports will help identify trends in antimicrobial use, enabling better decision-making to combat antimicrobial resistance and protect both animal and human health in Europe.
For more information, see here.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Swissmedic: Haemovigilance Annual Report 2025
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
European Medicines Agency: Global regulators call for advancing alternatives to animal testing